期刊文献+

中西医结合治疗HIV/AIDS8例临床分析 被引量:8

Clinical Analysis of 8 patients with HIV/AIDS Treated with Integrated Traditional Chinese Medicine and Western Medicine
下载PDF
导出
摘要 [目的]通过对8例人类免疫缺陷病毒/艾滋病(HIV/AIDS)患者进行中西医结合干预治疗,观察其临床疗效。[方法]8例HIV/AIDS患者在服用西药抗病毒药物双汰芝(AZT+3TC)、奈韦拉平(NVP)的同时给予中药扶正排毒胶囊,疗程6个月,治疗前后记录症状体征积分,并检测T细胞亚群、病毒载量以及丙氨酸转氨酶(ALT)、谷草转氨酶(AST)、肌酐(CR)、血液尿素氮(BUN)和体质量。[结果]治疗后症状体征积分较疗前明显下降(P<0.05),CD4计数有一定的升高(P>0.05),病毒载量在治疗6个月后全部低于检测下限;ALT恢复至正常范围;体质量保持稳定(P>0.05)。[结论]通过中西医结合干预治疗,可显著改善艾滋病患者的症状,提高免疫功能,抑制HIV的复制,降低西药的毒副作用。 [Objective] To observe the therapeutic effect in 8 patients with HIV/AIDS with integrated modem medicine and TCM. [Methods] 8 eases with IV/AIDS were treated with Strengthening Zheng and eliminating toxin capsttle and Combivir and NVP simultaneously for 6 months. The symptoms integral , the number of T cell subgroup, vires loading, ALT, AST, CR, BUN and body weight were recorded before and after treatment. [Results] After treatment the symptom integral was reduced (P〈0.05). The CD4 count was raised in a certain degree P〉0.05). All the vires loadings were located under the lower limit of test 6 months later. ALT came back to normal scope. Body weight remained in a stable condition(P〉0.05). [Conclusiou] The treatment of integrated modem medicine and TCM can obviously improve the symptoms and raise immune function, inhabit HIV duplication, reduce side effect of modem medicine.
出处 《天津中医药》 CAS 2006年第2期123-125,共3页 Tianjin Journal of Traditional Chinese Medicine
关键词 艾滋病 中西医结合治疗 临床研究 HIV/AIDS Treatment of integrated modem medicine and TCM Clinical research
  • 相关文献

参考文献5

二级参考文献14

  • 1陈泽霖.5403例正常人舌象检查分析[J].中医杂志,1981,22(2):18-20.
  • 2Corzo JE,Gomez-Mateos J,Rueda A.Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients[J].HIV Clin Trials,2003,4(5):337-346.
  • 3Shah SS,Rodriguez T,McGowan JP.Miller Fisher variant of Guillain-Barre syndrome associated with lactic acidosis and stavudine therapy.Clin Infect Dis[J].2003,36(10):131-133.
  • 4Montaner IS,Cote HC,Harris M.Mitochnodrial toxicity in the era of HA ART:evaluating venous lactate and peripheral blood mitochnodrial DNA in HIV-infected patients taking antiretr oviral therapy[J].J Acquir Immune Defic Syndr,2003,34 Suppl(1):S85-90.
  • 5Gerard Y,Viget N,Yazdanpanah Y.Hyperlactataemia during antiretrovir al therapy:incidences,clinical data and treatment[J].Therapie,2003,58(2):153-158.
  • 6Kontorinis N,Dieterich DT.Toxicity of non-nucleoside analogue reve rse transcriptase inhibitors[J].Semin Li ver Dis,2003,23(2):173-182.
  • 7Rhew DC,Bernal M,Aguilar D,et al.Association between protease in hibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus:a system atic review[J].Clin Infect Dis,2003,37(7):959-972.
  • 8Penzak SR,Chuck SK.Scand J Infect Dis,2000,32(2):111-123.
  • 9Graham NM.J Acquir Immune Defic Syndr,2000:25 (Suppl 1):S4-11.
  • 10McComsey G,Maa JF.Host factors maybe more important than choice of antiretrovirals in the development of lipoatrophy[J].AIDS Read,2003,13(11):539-542,559.

共引文献99

同被引文献168

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部